Michael A Lyon - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Organic Letters|December 21, 2004

Glyoxylic acid and MP-glyoxylate: efficient formaldehyde equivalents in the 3-CC of 2-aminoazines, aldehydes, and isonitrilesMichael A Lyon, Timothy S Kercher

Nature Reviews. Drug Discovery|December 4, 2002

Dual-specificity phosphatases as targets for antineoplastic agentsMichael A Lyon, Alexander P Ducruet, Peter Wipf, et al.

The Journal of Biological Chemistry|September 28, 2004

Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activitySheara W Fewell, Christine M Smith, Michael A Lyon, et al.

Oncology Research|September 23, 2011

Single-agent inhibition of Chk1 is antiproliferative in human cancer cell lines in vitro and inhibits tumor xenograft growth in vivoKurtis D Davies, Michael J Humphries, Francis X Sullivan, et al.

Chemmedchem|September 15, 2011

Discovery of a pharmacologically active antagonist of the two-pore-domain potassium channel K2P9.1 (TASK-3)Craig A Coburn, Yunfu Luo, Mingxiang Cui, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Organic Letters|December 21, 2004

Glyoxylic acid and MP-glyoxylate: efficient formaldehyde equivalents in the 3-CC of 2-aminoazines, aldehydes, and isonitrilesMichael A Lyon, Timothy S Kercher

Nature Reviews. Drug Discovery|December 4, 2002

Dual-specificity phosphatases as targets for antineoplastic agentsMichael A Lyon, Alexander P Ducruet, Peter Wipf, et al.

The Journal of Biological Chemistry|September 28, 2004

Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activitySheara W Fewell, Christine M Smith, Michael A Lyon, et al.

Oncology Research|September 23, 2011

Single-agent inhibition of Chk1 is antiproliferative in human cancer cell lines in vitro and inhibits tumor xenograft growth in vivoKurtis D Davies, Michael J Humphries, Francis X Sullivan, et al.

Chemmedchem|September 15, 2011

Discovery of a pharmacologically active antagonist of the two-pore-domain potassium channel K2P9.1 (TASK-3)Craig A Coburn, Yunfu Luo, Mingxiang Cui, et al.

Pageof 1